Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Free Cash Flow: 2020-2024

Historic Free Cash Flow for Pyxis Oncology (PYXS) over the last 5 years, with Dec 2024 value amounting to -$57.9 million.

  • Pyxis Oncology's Free Cash Flow rose 9.46% to -$13.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$72.4 million, marking a year-over-year change of. This contributed to the annual value of -$57.9 million for FY2024, which is 25.22% up from last year.
  • Per Pyxis Oncology's latest filing, its Free Cash Flow stood at -$57.9 million for FY2024, which was up 25.22% from -$77.4 million recorded in FY2023.
  • Pyxis Oncology's 5-year Free Cash Flow high stood at -$11.6 million for FY2020, and its period low was -$95.7 million during FY2022.
  • In the last 3 years, Pyxis Oncology's Free Cash Flow had a median value of -$77.4 million in 2023 and averaged -$77.0 million.
  • In the last 5 years, Pyxis Oncology's Free Cash Flow plummeted by 210.07% in 2021 and then increased by 25.22% in 2024.
  • Yearly analysis of 5 years shows Pyxis Oncology's Free Cash Flow stood at -$11.6 million in 2020, then slumped by 210.07% to -$35.9 million in 2021, then plummeted by 166.92% to -$95.7 million in 2022, then climbed by 19.11% to -$77.4 million in 2023, then grew by 25.22% to -$57.9 million in 2024.